MicroRNAs in the Brain: It's Regulatory Role in Neuroinflammation

[1]  Z. Hong,et al.  miR‐21 represses FasL in microglia and protects against microglia‐mediated neuronal cell death following hypoxia/ischemia , 2012, Glia.

[2]  Salvatore Campo,et al.  Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review). , 2012, International journal of oncology.

[3]  H. Grosshans,et al.  MicroRNA turnover: when, how, and why. , 2012, Trends in biochemical sciences.

[4]  P. V. van Rijen,et al.  MicroRNA-146a: A Key Regulator of Astrocyte-Mediated Inflammatory Response , 2012, PloS one.

[5]  Guojun Bu,et al.  Alzheimer's β-Secretase (BACE1) Regulates the cAMP/PKA/CREB Pathway Independently of β-Amyloid , 2012, The Journal of Neuroscience.

[6]  H. Weiner,et al.  Detection of microRNAs in microglia by real-time PCR in normal CNS and during neuroinflammation. , 2012, Journal of visualized experiments : JoVE.

[7]  Qing Jing,et al.  MicroRNA degradation and turnover: regulating the regulators , 2012, Wiley interdisciplinary reviews. RNA.

[8]  Zheng Li,et al.  Expression of miRNAs and Their Cooperative Regulation of the Pathophysiology in Traumatic Brain Injury , 2012, PloS one.

[9]  Sunit K. Singh,et al.  HIV-1 Tat C-mediated regulation of tumor necrosis factor receptor-associated factor-3 by microRNA 32 in human microglia , 2012, Journal of Neuroinflammation.

[10]  W. Brück,et al.  MicroRNA regulation in experimental autoimmune encephalomyelitis in mice and marmosets resembles regulation in human multiple sclerosis lesions , 2012, Journal of Neuroimmunology.

[11]  M. Maral Mouradian,et al.  MicroRNAs in Parkinson's disease , 2012, Neurobiology of Disease.

[12]  Seena K. Ajit.  Circulating microRNAs as Biomarkers, Therapeutic Targets, and Signaling Molecules , 2012, Sensors.

[13]  S. Booth,et al.  MicroRNA 146a (miR-146a) Is Over-Expressed during Prion Disease and Modulates the Innate Immune Response and the Microglial Activation State , 2012, PloS one.

[14]  Xiulian Sun,et al.  Regulation of β‐site APP‐cleaving enzyme 1 gene expression and its role in Alzheimer’s Disease , 2012, Journal of neurochemistry.

[15]  Sunhee C. Lee,et al.  Interferon regulatory factor 3 inhibits astrocyte inflammatory gene expression through suppression of the proinflammatory miR‐155 and miR‐155* , 2011, Glia.

[16]  King-Jen Chang,et al.  miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans. , 2011, The Journal of clinical investigation.

[17]  H. Weiner,et al.  Silencing MicroRNA-155 Ameliorates Experimental Autoimmune Encephalomyelitis , 2011, The Journal of Immunology.

[18]  E. Chan,et al.  MicroRNA in TLR signaling and endotoxin tolerance , 2011, Cellular and Molecular Immunology.

[19]  Susan R. Quinn,et al.  A trio of microRNAs that control Toll-like receptor signalling. , 2011, International immunology.

[20]  A. Basu,et al.  RIG-I Mediates Innate Immune Response in Mouse Neurons Following Japanese Encephalitis Virus Infection , 2011, PloS one.

[21]  H. Bramlett,et al.  Therapeutic hypothermia alters microRNA responses to traumatic brain injury in rats , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[22]  H. Grosshans,et al.  Target-mediated protection of endogenous microRNAs in C. elegans. , 2011, Developmental cell.

[23]  L. O’Neill,et al.  MicroRNAs: the fine-tuners of Toll-like receptor signalling , 2011, Nature Reviews Immunology.

[24]  Shuang Huang,et al.  Uracils at nucleotide position 9–11 are required for the rapid turnover of miR-29 family , 2011, Nucleic acids research.

[25]  P. Nelson,et al.  MicroRNAs in CNS injury: Potential roles and therapeutic implications , 2011, BioEssays : news and reviews in molecular, cellular and developmental biology.

[26]  H. Weiner,et al.  MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-α–PU.1 pathway , 2011, Nature Medicine.

[27]  T. Dinan,et al.  MicroRNAs: a novel therapeutic target for schizophrenia. , 2011, Current pharmaceutical design.

[28]  Michael J. Taylor,et al.  HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy , 2010, Neurology.

[29]  Chunmei Wang,et al.  Inducible microRNA-155 Feedback Promotes Type I IFN Signaling in Antiviral Innate Immunity by Targeting Suppressor of Cytokine Signaling 1 , 2010, The Journal of Immunology.

[30]  K. Tufekci,et al.  MicroRNAs and Multiple Sclerosis , 2010, Autoimmune diseases.

[31]  A. Basu,et al.  Krüppel-like factor 4, a novel transcription factor regulates microglial activation and subsequent neuroinflammation , 2010, Journal of Neuroinflammation.

[32]  B. Davis-Dusenbery,et al.  Mechanisms of control of microRNA biogenesis. , 2010, Journal of biochemistry.

[33]  E. Granieri,et al.  Altered miRNA expression in T regulatory cells in course of multiple sclerosis , 2010, Journal of Neuroimmunology.

[34]  Mathew B. Cox,et al.  MicroRNAs miR-17 and miR-20a Inhibit T Cell Activation Genes and Are Under-Expressed in MS Whole Blood , 2010, PloS one.

[35]  R. Goodman,et al.  MicroRNA pathways in neural development and plasticity , 2010, Current Opinion in Neurobiology.

[36]  Julie A Saugstad,et al.  MicroRNAs as Effectors of Brain Function with Roles in Ischemia and Injury, Neuroprotection, and Neurodegeneration , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[37]  K. Khalili,et al.  CCL8/MCP‐2 is a target for mir‐146a in HIV‐1‐infected human microglial cells , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  K. Sonntag,et al.  MicroRNAs and deregulated gene expression networks in neurodegeneration , 2010, Brain Research.

[39]  M. Hollenberg,et al.  MicroRNA profiling reveals new aspects of HIV neurodegeneration: caspase‐6 regulates astrocyte survival , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[40]  R. Kanwar,et al.  MicroRNA in human cancer and chronic inflammatory diseases. , 2010, Frontiers in bioscience.

[41]  Michael B. Stadler,et al.  Characterizing Light-Regulated Retinal MicroRNAs Reveals Rapid Turnover as a Common Property of Neuronal MicroRNAs , 2010, Cell.

[42]  L. Kappos,et al.  Altered expression of miR‐17‐5p in CD4+ lymphocytes of relapsing–remitting multiple sclerosis patients , 2010, European journal of immunology.

[43]  S. Griffiths-Jones,et al.  miRBase: microRNA Sequences and Annotation , 2010, Current protocols in bioinformatics.

[44]  M. Diamond,et al.  Prion-like mechanisms in neurodegenerative diseases , 2010, Nature Reviews Neuroscience.

[45]  S. Stupp,et al.  BMPR1a and BMPR1b Signaling Exert Opposing Effects on Gliosis after Spinal Cord Injury , 2010, The Journal of Neuroscience.

[46]  E. Pålsson-McDermott,et al.  Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21 , 2010, Nature Immunology.

[47]  Ryan M. O’Connell,et al.  Physiological and pathological roles for microRNAs in the immune system , 2010, Nature Reviews Immunology.

[48]  B. Cullen.  Five Questions about Viruses and MicroRNAs , 2010, PLoS pathogens.

[49]  P. Siesjö,et al.  What has inflammation to do with traumatic brain injury? , 2010, Child's Nervous System.

[50]  H. Lassmann,et al.  MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. , 2009, Brain : a journal of neurology.

[51]  Jiuhong Kang,et al.  MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis , 2009, Nature Immunology.

[52]  K. Kosik,et al.  MicroRNAs Potentiate Neural Development , 2009, Neuron.

[53]  A. Pivarcsi,et al.  microRNAs in Inflammation , 2009, International reviews of immunology.

[54]  Yuhai Zhao,et al.  HSV-1 infection of human brain cells induces miRNA-146a and Alzheimer-type inflammatory signaling , 2009, Neuroreport.

[55]  Hans-Peter Lenhof,et al.  Multiple Sclerosis: MicroRNA Expression Profiles Accurately Differentiate Patients with Relapsing-Remitting Disease from Healthy Controls , 2009, PloS one.

[56]  Ye Zeng,et al.  Analysis of microRNA expression profiles during the cell cycle in synchronized HeLa cells. , 2009, BMB reports.

[57]  W. Schulz-Schaeffer,et al.  Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease , 2009, Molecular Neurodegeneration.

[58]  Jian-ning Zhang,et al.  Microarray based analysis of microRNA expression in rat cerebral cortex after traumatic brain injury , 2009, Brain Research.

[59]  A. Hata,et al.  Regulation of MicroRNA Biogenesis: A miRiad of mechanisms , 2009, Cell Communication and Signaling.

[60]  Walter J. Lukiw,et al.  Micro-RNA abundance and stability in human brain: Specific alterations in Alzheimer's disease temporal lobe neocortex , 2009, Neuroscience Letters.

[61]  Pin Wang,et al.  MicroRNA-146a Feedback Inhibits RIG-I-Dependent Type I IFN Production in Macrophages by Targeting TRAF6, IRAK1, and IRAK21 , 2009, The Journal of Immunology.

[62]  M. Lindsay,et al.  microRNAs and the immune response. , 2008, Trends in immunology.

[63]  Marina A. Lynch,et al.  The Multifaceted Profile of Activated Microglia , 2009, Molecular Neurobiology.

[64]  J. A. Lozano,et al.  Differential Micro RNA Expression in PBMC from Multiple Sclerosis Patients , 2009, PloS one.

[65]  P. Dash,et al.  Traumatic brain injury alters expression of hippocampal microRNAs: Potential regulators of multiple pathophysiological processes , 2009, Journal of neuroscience research.

[66]  A. Nath,et al.  Role of Tat Protein in HIV Neuropathogenesis , 2009, Neurotoxicity Research.

[67]  A. Delacourte,et al.  MicroRNA regulation of Alzheimer's Amyloid precursor protein expression , 2009, Neurobiology of Disease.

[68]  E. Sontheimer,et al.  Origins and Mechanisms of miRNAs and siRNAs , 2009, Cell.

[69]  I. Plante,et al.  MicroRNA-298 and MicroRNA-328 Regulate Expression of Mouse β-Amyloid Precursor Protein-converting Enzyme 1* , 2009, Journal of Biological Chemistry.

[70]  Klaus Rajewsky,et al.  MicroRNA Control in the Immune System: Basic Principles , 2009, Cell.

[71]  Yi Xing,et al.  The Bifunctional microRNA miR-9/miR-9* Regulates REST and CoREST and Is Downregulated in Huntington's Disease , 2008, The Journal of Neuroscience.

[72]  Walter J. Lukiw,et al.  An NF-κB-sensitive Micro RNA-146a-mediated Inflammatory Circuit in Alzheimer Disease and in Stressed Human Brain Cells* , 2008, Journal of Biological Chemistry.

[73]  S. Booth,et al.  A miRNA Signature of Prion Induced Neurodegeneration , 2008, PloS one.

[74]  E. Olson,et al.  Toward microRNA-based therapeutics for heart disease: the sense in antisense. , 2008, Circulation research.

[75]  V. Lee,et al.  Mechanism of Ca2+ Disruption in Alzheimer's Disease by Presenilin Regulation of InsP3 Receptor Channel Gating , 2008, Neuron.

[76]  S. Cohen,et al.  microRNAs in neurodegeneration , 2008, Current Opinion in Neurobiology.

[77]  F. Gillardon,et al.  MicroRNA and proteome expression profiling in early‐symptomatic α‐synuclein(A30P)‐transgenic mice , 2008, Proteomics. Clinical applications.

[78]  A. Bruni,et al.  Late onset familial Alzheimer's disease: novel presenilin 2 mutation and PS1 E318G polymorphism , 2008, Journal of Neurology.

[79]  Christopher C. J. Miller,et al.  The FE65 proteins and Alzheimer's disease , 2008, Journal of neuroscience research.

[80]  Elena Cattaneo,et al.  A microRNA-based gene dysregulation pathway in Huntington's disease , 2008, Neurobiology of Disease.

[81]  Philip C. J. Donoghue,et al.  MicroRNAs and the advent of vertebrate morphological complexity , 2008, Proceedings of the National Academy of Sciences.

[82]  Osamu Takeuchi,et al.  MDA5/RIG-I and virus recognition. , 2008, Current opinion in immunology.

[83]  Guiliang Tang,et al.  The Expression of MicroRNA miR-107 Decreases Early in Alzheimer's Disease and May Accelerate Disease Progression through Regulation of β-Site Amyloid Precursor Protein-Cleaving Enzyme 1 , 2008, The Journal of Neuroscience.

[84]  M. Cairns,et al.  Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. , 2008, Human molecular genetics.

[85]  T. Foster,et al.  Ocular HSV-1 Latency, Reactivation and Recurrent Disease , 2008, Seminars in ophthalmology.

[86]  Peter T. Nelson,et al.  MicroRNAs (miRNAs) in Neurodegenerative Diseases , 2008, Brain pathology.

[87]  R. Neve.  Alzheimer's disease sends the wrong signals – a perspective , 2008, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[88]  A. Roses,et al.  Identification of miRNA Changes in Alzheimer's Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways , 2008 .

[89]  D A Bennett,et al.  Relation of cognitive activity to risk of developing Alzheimer disease , 2007, Neurology.

[90]  Muller Fabbri,et al.  Modulation of miR-155 and miR-125b Levels following Lipopolysaccharide/TNF-α Stimulation and Their Possible Roles in Regulating the Response to Endotoxin Shock1 , 2007, The Journal of Immunology.

[91]  W. Lukiw,et al.  Induction of specific micro RNA (miRNA) species by ROS-generating metal sulfates in primary human brain cells. , 2007, Journal of inorganic biochemistry.

[92]  P. George-Hyslop,et al.  The γ /η-Secretase-Derived APP Intracellular Domain Fragments Regulate p53 , 2007 .

[93]  S. Hébert,et al.  miRNAs in Neurodegeneration , 2007, Science.

[94]  G. Hannon,et al.  A MicroRNA Feedback Circuit in Midbrain Dopamine Neurons , 2007, Science.

[95]  Nilüfer Ertekin-Taner,et al.  Genetics of Alzheimer's disease: a centennial review. , 2007, Neurologic clinics.

[96]  Anton J. Enright,et al.  Requirement of bic/microRNA-155 for Normal Immune Function , 2007, Science.

[97]  W. Lukiw,et al.  Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus , 2007, Neuroreport.

[98]  David Baltimore,et al.  MicroRNA-155 is induced during the macrophage inflammatory response , 2007, Proceedings of the National Academy of Sciences.

[99]  P. S. St George-Hyslop,et al.  The gamma/epsilon-secretase-derived APP intracellular domain fragments regulate p53. , 2007, Current Alzheimer research.

[100]  Joel S Parker,et al.  microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder , 2007, Genome Biology.

[101]  W. Streit.  Microglial senescence: does the brain's immune system have an expiration date? , 2006, Trends in Neurosciences.

[102]  D. Baltimore,et al.  NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses , 2006, Proceedings of the National Academy of Sciences.

[103]  L. Del Valle,et al.  HIV disorders of the brain: pathology and pathogenesis. , 2006, Frontiers in bioscience : a journal and virtual library.

[104]  D. Campion,et al.  APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy , 2006, Nature Genetics.

[105]  R. Pillai.  MicroRNA function: multiple mechanisms for a tiny RNA? , 2005, RNA.

[106]  E. Ponomarev,et al.  Microglial cell activation and proliferation precedes the onset of CNS autoimmunity , 2005, Journal of neuroscience research.

[107]  Keith Bowman,et al.  Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs , 2005, Nature Biotechnology.

[108]  V. Kim,et al.  The Drosha-DGCR8 complex in primary microRNA processing. , 2004, Genes & development.

[109]  Sanghyuk Lee,et al.  MicroRNA genes are transcribed by RNA polymerase II , 2004, The EMBO journal.

[110]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[111]  D. Sparks,et al.  Dystrophic microglia in the aging human brain , 2004, Glia.

[112]  G. Cheng,et al.  Toll-like receptors and innate antiviral responses. , 2003, Current opinion in immunology.

[113]  M. Ball,et al.  Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: Transcription and neurotrophic factor down‐regulation and up‐regulation of apoptotic and pro‐inflammatory signaling , 2002, Journal of neuroscience research.

[114]  N. Bazan,et al.  Prostaglandins and other lipid mediators in Alzheimer's disease. , 2002, Prostaglandins & other lipid mediators.

[115]  H. Adle-Biassette,et al.  Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments. , 2001, Clinical neuropathology.

[116]  B. Reinhart,et al.  Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA , 2000, Nature.

[117]  N. Berman,et al.  Selective chemokine mRNA expression following brain injury , 1998, Brain Research.

[118]  M. Klemsz,et al.  The transcription factor PU.1 is involved in macrophage proliferation , 1996, The Journal of experimental medicine.

[119]  N. Woychik,et al.  Regulating the regulators. , 1994, Trends in biochemical sciences.

[120]  R J Fletterick,et al.  Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[121]  M. Lehtinen,et al.  Phospholipase A2 activity is copurified together with herpes simplex virus-specified Fc receptor proteins. , 1988, Intervirology.